Omapatrilat, an Angiotensin-Converting Enzyme and Neutral Endopeptidase Inhibitor, Attenuates Early Atherosclerosis in Diabetic and in Nondiabetic Low-Density Lipoprotein Receptor-Deficient Mice

Author: Levy Z.  

Publisher: Informa Healthcare

ISSN: 1560-4284

Source: International Journal of Experimental Diabetes Research, Vol.4, Iss.1, 2003-01, pp. : 59-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content